Qin-Shi Zhao Selected Research

Qin-Shi Zhao Research Topics

Disease

17	Neoplasms (Cancer) 03/2024 - 05/2008
4	Type 2 Diabetes Mellitus (MODY) 09/2022 - 07/2013
3	Inflammation (Inflammations) 06/2022 - 11/2014
2	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 12/2005
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 11/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 11/2007
1	Pain (Aches) 02/2024
1	Epilepsy (Aura) 02/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2022
1	Obesity 09/2022
1	Liver Diseases (Liver Disease) 06/2022
1	Alcoholic Fatty Liver 06/2022
1	Fibrosis (Cirrhosis) 06/2022
1	Hyperglycemia 03/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Cognitive Dysfunction 01/2022
1	Insulin Resistance 09/2021
1	Dyslipidemias (Dyslipidemia) 11/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2016
1	Acute Promyelocytic Leukemia 01/2016
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2015
1	Breast Neoplasms (Breast Cancer) 12/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2008
1	Carcinogenesis 05/2008
1	Stomach Neoplasms (Stomach Cancer) 05/2008
1	Lung Neoplasms (Lung Cancer) 05/2008
1	Leukemia 11/2007

Drug/Important Bio-Agent (IBA)

4	DiterpenesIBA 01/2016 - 12/2005
3	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 11/2007
2	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 11/2020
2	Blood Glucose (Blood Sugar)IBA 09/2021 - 11/2020
2	ChlA-FIBA 01/2020 - 11/2018
2	AcetylcholinesteraseIBA 12/2016 - 01/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2009 - 05/2008
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2009 - 05/2008
1	CytokinesIBA 03/2024
1	cryptotanshinoneIBA 03/2024
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 02/2024
1	Calcium Channels (Calcium Channel)IBA 02/2024
1	cyclovirobuxine DIBA 01/2023
1	AlkaloidsIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 12/2022
1	Oxidoreductases (Dehydrogenase)IBA 09/2022
1	alisol BIBA 06/2022
1	Amino Acids FDA Link 06/2022
1	Choline (Choline Chloride)IBA 06/2022
1	LipidsIBA 06/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 06/2022
1	KynurenineIBA 05/2022
1	Tryptophan (L-Tryptophan)FDA Link 05/2022
1	SaltsIBA 03/2022
1	Phosphotransferases (Kinase)IBA 03/2022
1	Sucrose (Saccharose)IBA 01/2022
1	rhyncophyllineIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	EnzymesIBA 11/2021
1	KGP94IBA 11/2021
1	EndopeptidasesIBA 11/2021
1	Cathepsin LIBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 09/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	cheliensisin AIBA 11/2018
1	LactonesIBA 11/2018
1	parthenolideIBA 11/2018
1	micheliolideIBA 11/2018
1	Neuroprotective AgentsIBA 11/2017
1	vibsanin AIBA 01/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	vibsanin BIBA 05/2015
1	NF-kappa B (NF-kB)IBA 11/2014
1	Kaurane DiterpenesIBA 11/2014
1	eriocalyxin BIBA 11/2014
1	Cysteine (L-Cysteine)FDA Link 11/2014
1	AcidsIBA 06/2012
1	1,4-O-diferuloylsecoisolariciresinolIBA 06/2012
1	OxazolesIBA 09/2011
1	neotanshinlactoneIBA 12/2010
1	PPAR-gamma AgonistsIBA 03/2009
1	Rosiglitazone (Avandia)FDA Link 03/2009
1	Peroxisome ProliferatorsIBA 03/2009
1	PPAR gammaIBA 03/2009
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 03/2009
1	oblongifolin CIBA 12/2008
1	GastrinsIBA 05/2008
1	Cholecystokinin B ReceptorIBA 05/2008
1	taxchinin AIBA 05/2008
1	brevifoliolIBA 05/2008
1	CaspasesIBA 11/2007
1	Arsenic Trioxide (Trisenox)FDA Link 11/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2007
1	Antineoplastic Agents (Antineoplastics)IBA 11/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2007

Therapy/Procedure

4	Therapeutics 06/2022 - 01/2016
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023
1	Immunotherapy 05/2022